Alexion (AstraZeneca)

Alexion is a brand that is dedicated to developing and providing life-transforming therapies for individuals suffering from devastating and rare diseases. With a global presence in over 50 countries, Alexion is committed to making a difference in the lives of patients and their caregivers. Their mission is to continuously innovate and create meaningful value in all that they do, with the goal of transforming the lives of those affected by rare diseases and devastating conditions. Alexion has made significant strides in the field, with 5 approved medicines and expertise in treating 7 rare diseases and devastating conditions. Their innovative work includes breakthrough treatments for conditions such as paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), neuromyelitis optica spectrum disorder (NMOSD), and hypophosphatasia (HPP), among others. With a strong commitment to integrity, inclusiveness, and community support, Alexion values the importance of its purpose and invests in talented individuals who share their passion. Together, they strive to make a positive impact and change lives for the better. As a brand, Alexion not only provides effective medications but also offers support services and resources for patients and their families.